81% of Online Abortion Businesses Send Drugs to Women Beyond the FDA’s 10-Week Timeframe Washington D.C.—A new Charlotte Lozier Institute (CLI) report discovered many online abortion drug sellers are violating U.S. laws, exceeding FDA safety limits, and selling unapproved and misbranded drugs to U.S. consumers. This blatant disregard for the law was only boosted by […] The post New CLI Report: Online Abortion Drug Sellers Violating U.S. Law and FDA Safety Limits appeared first on Lozier Institute .
Read →Tag
Abortion Industry
Content substantially addressing abortion industry.
Washington D.C.—Today, the Supreme Court temporarily blocked the 5th U.S. Circuit Court ruling that paused the nationwide remote shipment of abortion drugs, mifepristone and misoprostol, in Louisiana v. FDA. Dr. Ingrid Skop, board-certified OB-GYN and vice president of medical affairs at Charlotte Lozier Institute, responded: “For too long, the predatory abortion industry has prioritized ‘access’—in […] The post CLI OB-GYN Responds to Supreme Court’s Reinstatement of Mail-Order Abortions appeared first on Lozier Institute .
Read →Showing 2 of 2